AU1453102A - Novel proteins and nucleic acids encoding same - Google Patents

Novel proteins and nucleic acids encoding same

Info

Publication number
AU1453102A
AU1453102A AU1453102A AU1453102A AU1453102A AU 1453102 A AU1453102 A AU 1453102A AU 1453102 A AU1453102 A AU 1453102A AU 1453102 A AU1453102 A AU 1453102A AU 1453102 A AU1453102 A AU 1453102A
Authority
AU
Australia
Prior art keywords
nucleic acids
acids encoding
encoding same
novel proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU1453102A
Inventor
K Spaderna Steven
Tchernev Velizar
Liu Xiaohong
Shenoy Suresh
Spytek Kimberly
Zerhusen Bryan
Patturajan Meera
J Taupier Raymond Jr
Rastelli Luca
M Grosse William
S Szekeres Edward
Alsobrook Ii John
M Lepley Denise
Shen Lei
E Burgess Catherine
A Shimkets Richard
Padigaru Muralidhara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US21585600P priority Critical
Priority to US21590200P priority
Priority to US21585400P priority
Priority to US21672200P priority
Priority to US21658600P priority
Priority to US21658500P priority
Priority to US21899200P priority
Priority to US21862200P priority
Priority to US22128500P priority
Priority to US26873401P priority
Priority to US27426001P priority
Priority to US27985601P priority
Application filed by CuraGen Corp filed Critical CuraGen Corp
Priority to PCT/US2001/021249 priority patent/WO2002006339A2/en
Publication of AU1453102A publication Critical patent/AU1453102A/en
Application status is Pending legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
AU1453102A 2000-07-03 2001-06-25 Novel proteins and nucleic acids encoding same Pending AU1453102A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US21585600P true 2000-07-03 2000-07-03
US21590200P true 2000-07-03 2000-07-03
US21585400P true 2000-07-03 2000-07-03
US21658600P true 2000-07-07 2000-07-07
US21658500P true 2000-07-07 2000-07-07
US21672200P true 2000-07-07 2000-07-07
US21899200P true 2000-07-17 2000-07-17
US21862200P true 2000-07-17 2000-07-17
US22128500P true 2000-07-27 2000-07-27
US26873401P true 2001-02-14 2001-02-14
US27426001P true 2001-03-08 2001-03-08
US27985601P true 2001-03-29 2001-03-29
PCT/US2001/021249 WO2002006339A2 (en) 2000-07-03 2001-07-03 Proteins and nucleic acids encoding same

Publications (1)

Publication Number Publication Date
AU1453102A true AU1453102A (en) 2002-01-30

Family

ID=27583802

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1453102A Pending AU1453102A (en) 2000-07-03 2001-06-25 Novel proteins and nucleic acids encoding same
AU2002214531A Abandoned AU2002214531A1 (en) 2000-07-03 2001-07-03 Proteins and nucleic acids encoding same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002214531A Abandoned AU2002214531A1 (en) 2000-07-03 2001-07-03 Proteins and nucleic acids encoding same

Country Status (3)

Country Link
US (1) US20040014081A1 (en)
AU (2) AU1453102A (en)
WO (1) WO2002006339A2 (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003085096A2 (en) * 2002-04-01 2003-10-16 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
DE10213762A1 (en) * 2002-03-26 2003-10-09 Boehringer Ingelheim Int New costimulatory molecule and its use
US20030215852A1 (en) * 2002-04-01 2003-11-20 Wyeth Novel pancortin-Pablo protein interactions and methods of use thereof
EP1575492A4 (en) * 2002-06-04 2007-05-09 Avalon Pharmaceuticals Cancer-linked gene as target for chemotherapy
US20040101847A1 (en) * 2002-11-22 2004-05-27 Isis Pharmaceuticals Inc. Modulation of Notch2 expression
CA2511522A1 (en) * 2002-12-26 2004-07-15 Takeda Pharmaceutical Company Limited Novel proteins and use thereof
SG195524A1 (en) 2003-11-06 2013-12-30 Seattle Genetics Inc Monomethylvaline compounds capable of conjugation to ligands
NZ579482A (en) 2004-06-01 2011-02-25 Genentech Inc Antibody drug conjugates and methods
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
SI1791565T1 (en) 2004-09-23 2016-08-31 Genentech, Inc. Cysteine engineered antibodies and conjugates
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
JP2007063225A (en) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd Imidazopyridine compound
EP2154245B1 (en) 2005-09-02 2015-11-11 Toray Industries, Inc. Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient
JP5302012B2 (en) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド Glucokinase activators
EP2049518B1 (en) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents.
EP2502628B1 (en) * 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
EP2091947A2 (en) 2006-12-20 2009-08-26 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
CN102245773B (en) 2008-11-03 2014-08-27 阿莱斯亚生物疗法股份有限公司 Antibodies that specifically block the biological activity of a tumor antigen
WO2011031870A1 (en) 2009-09-09 2011-03-17 Centrose, Llc Extracellular targeted drug conjugates
AU2011239507B2 (en) 2010-04-15 2015-04-09 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
AU2011265054B2 (en) 2010-06-08 2016-09-15 Genentech, Inc. Cysteine engineered antibodies and conjugates
ES2544608T3 (en) 2010-11-17 2015-09-02 Genentech, Inc. Conjugates of the antibody and alaninyl-maytansinol
JP6294221B2 (en) 2011-03-31 2018-03-14 アー・デー・ツェー・セラピューティクス・エス・アー Antibodies and antigen-binding fragments thereof to the kidney-associated antigens 1
RU2638806C2 (en) 2011-05-12 2017-12-15 Дженентек, Инк. Lc-ms/ms method for multiple reactions monitoring to identify therapeutic antibodies in animal species using framework signature peptides
WO2013130093A1 (en) 2012-03-02 2013-09-06 Genentech, Inc. Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
HUE035694T2 (en) 2012-10-12 2018-05-28 Adc Therapeutics Sa Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
JP5993093B2 (en) 2012-10-12 2016-09-14 メドイミューン・リミテッドMedImmune Limited Pyrrolo benzodiazepines and their complexes
AU2013328625B2 (en) 2012-10-12 2016-12-15 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
CN105050661B (en) 2012-10-12 2018-03-30 Adc疗法责任有限公司 Pyrrolo benzodiazepine - antibody conjugate
JP6307519B2 (en) 2012-12-21 2018-04-04 メドイミューン・リミテッドMedImmune Limited Pyrrolo benzodiazepines and its conjugate
JP6527466B2 (en) 2012-12-21 2019-06-05 メドイミューン・リミテッドMedImmune Limited Asymmetric pyrrolobenzodiazepine dimers for use in the treatment of proliferative and autoimmune diseases
NZ710745A (en) 2013-03-13 2019-03-29 Genentech Inc Pyrrolobenzodiazepines and conjugates thereof
NZ710746A (en) 2013-03-13 2018-11-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
US20160031887A1 (en) 2013-03-13 2016-02-04 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
CA2918139A1 (en) 2013-08-12 2015-02-19 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
WO2015095212A1 (en) 2013-12-16 2015-06-25 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
WO2015052532A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
US9950078B2 (en) 2013-10-11 2018-04-24 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
MX2016007825A (en) 2013-12-16 2016-09-07 Genentech Inc Peptidomimetic compounds and antibody-drug conjugates thereof.
BR112016013861A2 (en) 2013-12-16 2017-10-10 Genentech Inc antibody and conjugated drug, compound, method of treatment and pharmaceutical composition
WO2016037644A1 (en) 2014-09-10 2016-03-17 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
JP2017531620A (en) 2014-09-12 2017-10-26 ジェネンテック, インコーポレイテッド Cysteine ​​engineered antibodies and conjugates
US10149913B2 (en) 2014-09-12 2018-12-11 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
BR112017005393A2 (en) 2014-09-17 2017-12-05 Genentech Inc compound of formula I, the method of preparation of a conjugate of formula, formula A1 conjugate, composition comprising a mixture of antibody-drug conjugate compounds, pharmaceutical composition and use of a conjugate or a composition
AU2015358532A1 (en) 2014-12-03 2017-06-29 Genentech, Inc. Quaternary amine compounds and antibody-drug conjugates thereof
EP3093043B1 (en) 2015-05-13 2018-11-14 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10058613B2 (en) 2015-10-02 2018-08-28 Genentech, Inc. Pyrrolobenzodiazepine antibody drug conjugates and methods of use
EP3362100A1 (en) 2015-10-16 2018-08-22 Genentech, Inc. Hindered disulfide drug conjugates
WO2017068511A1 (en) 2015-10-20 2017-04-27 Genentech, Inc. Calicheamicin-antibody-drug conjugates and methods of use
CN108700598A (en) 2016-03-25 2018-10-23 豪夫迈·罗氏有限公司 Multiplexed total antibody and antibody-conjugated drug quantification assay
EP3458101A1 (en) 2016-05-20 2019-03-27 H. Hoffnabb-La Roche Ag Protac antibody conjugates and methods of use
EP3465221A1 (en) 2016-05-27 2019-04-10 H. Hoffnabb-La Roche Ag Bioanalytical method for the characterization of site-specific antibody-drug conjugates
US20170348422A1 (en) 2016-06-06 2017-12-07 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
WO2018031662A1 (en) 2016-08-11 2018-02-15 Genentech, Inc. Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
WO2018065501A1 (en) 2016-10-05 2018-04-12 F. Hoffmann-La Roche Ag Methods for preparing antibody drug conjugates
WO2019060398A1 (en) 2017-09-20 2019-03-28 Ph Pharma Co., Ltd. Thailanstatin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786158A (en) * 1992-04-30 1998-07-28 Yale University Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
US5750652A (en) * 1994-01-21 1998-05-12 Yale University Deltex proteins

Also Published As

Publication number Publication date
AU2002214531A1 (en) 2002-01-30
WO2002006339A2 (en) 2002-01-24
WO2002006339A3 (en) 2003-07-31
US20040014081A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
AU8885801A (en) Novel receptor nucleic acids and polypeptides
AU1412702A (en) Nucleic acids and proteins from streptococcus groups a and b
PT1490386E (en) Novel polypeptide and nucleic acids encoding the same
HU0201783A3 (en) Anti-alfavbetha3 recombinant human antibodies, nucleic acids encoding same and methods
EP1242443A4 (en) Novel nucleic acids and polypeptides
AU6802801A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7315001A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
AU6531101A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002243415A1 (en) Nod2 nucleic acids and proteins
AU4140501A (en) Nucleic acids, proteins, and antibodies
AU7488801A (en) Nucleic acids, proteins, and antibodies
AU6678701A (en) Nucleic acids, proteins, and antibodies
AU2001268714A1 (en) EV-VEGF nucleic acids and polypeptides and methods of use
EP1381621A4 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU1661002A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU5077101A (en) Nucleic acids, proteins, and antibodies
AU6871401A (en) Ev-vegf nucleic acids and polypeptides and methods of use
AU6701401A (en) Modified morbillivirus v proteins
AU4341502A (en) Nod2 nucleic acids and proteins
AU4925101A (en) Novel nucleic acids and polypeptides